Recombinant human parathyroid hormone (1-34) increases bone mineral density in men with both idiopathic and hypogonadal osteoporosis.

被引：0
|
作者：
Orwoll, ES
Scheele, WH
Clancy, AD
Adami, S
Syversen, U
Kaufman, JM
Diez-Perez, A
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1958
引用
收藏
页码：S379 / S379
页数：1
相关论文
共 50 条
  • [21] Comparison between recombinant human parathyroid hormone(1-34) and elcatonin in treatment of primary osteoporosis
    Yan Yang
    Xue-Jun Zhang
    Xian-Jun Zhu
    Lei Zhang
    Ming-Jing Bao
    Yang Xian
    Ji-Chuan Wu
    Li-Mei Liu
    Peng-Qiu Li
    [J]. Asian Pacific Journal of Tropical Medicine, 2015, (01) : 79 - 84
  • [22] Comparison between recombinant human parathyroid hormone (1-34) and elcatonin in treatment of primary osteoporosis
    Yang, Yan
    Zhang, Xue-Jun
    Zhu, Xian-Jun
    Zhang, Lei
    Bao, Ming-Jing
    Xian, Yang
    Wu, Ji-Chuan
    Liu, Li-Mei
    Li, Peng-Qiu
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2015, 8 (01) : 79 - 84
  • [23] Effect of intranasal salmon calcitonin on bone mineral density in men with idiopathic osteoporosis.
    Trovas, G
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S433 - S433
  • [24] A novel human parathyroid hormone (1-34) analog for the treatment of osteoporosis
    Feng, Jiao
    Liu, Yanhua
    Xing, Yun
    Wang, Huaqian
    Li, Taiming
    Liu, Jingjing
    Fan, Hao
    Cao, Rongyue
    [J]. PEPTIDES, 2009, 30 (06) : 1173 - 1180
  • [25] Recombinant human parathyroid hormone (1-34) therapy reduces the incidence of moderate/severe vertebral fractures in men with low bone density.
    Orwoll, E
    Scheele, WH
    Clancy, AD
    Adami, S
    Syversen, U
    Diez-Perez, A
    Myers, SL
    Mitlak, BH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S162 - S162
  • [26] PTH[1-34], but not alendronate, increases bone quality in trabecular bone in a rat model of osteoporosis.
    Jorgensen, N. R.
    Thorkildsen, C.
    Jensen, J. B.
    Petersen, J. S.
    Schwarz, P.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S297 - S297
  • [27] Recombinant Human Parathyroid Hormone Related Protein 1-34 and 1-84 and Their Roles in Osteoporosis Treatment
    Wang, Hua
    Liu, Jingning
    Yin, Ying
    Wu, Jun
    Wang, Zilu
    Miao, Dengshun
    Sun, Wen
    [J]. PLOS ONE, 2014, 9 (02):
  • [28] HUMAN PARATHYROID HORMONE-(1-34) INCREASES BONE MASS IN OVARIECTOMIZED AND ORCHIDECTOMIZED RATS
    HOCK, JM
    GERA, I
    FONSECA, J
    RAISZ, LG
    [J]. ENDOCRINOLOGY, 1988, 122 (06) : 2899 - 2904
  • [29] Parathyroid hormone (hPTH 1-34) and estrogen dramatically increases bone density in postmenopausal osteoporosis: A placebo-controlled randomized trial
    Roe, EB
    Cann, CF
    Sanchez, SD
    Bachetti, P
    Black, D
    Arnaud, CD
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S196 - S197
  • [30] Parathyroid hormone 1-34 (hPTH 1-34) and estrogen produce dramatic bone density increases in postmenopausal osteoporosis - Results from a placebo-controlled randomized trial.
    Roe, EB
    Sanchez, SD
    del Puerto, GA
    Pierini, E
    Bacchetti, P
    Cann, CE
    Arnaud, CD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S137 - S137
12345